Merck Invests $2 Billion in China’s Hansoh for Weight-Loss Drug
US drugmaker Merck has signed a licensing deal worth up to $2 billion with Chinese biotech company Hansoh Pharma for its experimental oral weight-loss drug HS-10535. The deal allows Merck to develop, manufacture, and sell the drug, which is similar to existing injectable rivals. The oral drug is currently in the preclinical stage of testing … Read more